Transitional cell carcinoma: Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
No edit summary |
||
| Line 13: | Line 13: | ||
}} | }} | ||
{{Search infobox}} | {{Search infobox}} | ||
{{ | {{Transitional cell carcinoma}} | ||
'''For patient information page click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information page click [[{{PAGENAME}} (patient information)|here]]''' | ||
Revision as of 20:09, 10 September 2012
| Transitional cell carcinoma | |
| ICD-O: | 8120-8130 |
|---|---|
|
Transitional cell carcinoma Microchapters |
|
Differentiating Transitional cell carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Transitional cell carcinoma On the Web |
|
American Roentgen Ray Society Images of Transitional cell carcinoma |
|
Directions to Hospitals Treating Transitional cell carcinoma |
|
Risk calculators and risk factors for Transitional cell carcinoma |
For patient information page click here
Steven C. Campbell, M.D., Ph.D.
Overview
Transitional cell carcinoma is a type of cancer that originates in the kidney, bladder or ureter. It is the most common type of bladder cancer. It arises from the transitional epithelium lining found in these organs.
Patient #1
Patient#2
